Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-30 Jenkins John Kenneth Director Grant or award +2,783 2,816
2024-05-30 CATLIN AVERY W Director Grant or award +2,783 4,350
2024-05-30 Salzmann Peter Director Grant or award +2,783 2,783
2024-05-30 Jacques Rachelle Suzanne Director Grant or award +2,783 2,783
2024-05-30 Ben Yong Director Grant or award +2,783 2,783
2024-05-30 HOLMER ALAN F Director Grant or award +2,783 4,162
2024-05-30 Altmeyer Anne Director Grant or award +2,783 2,783
2024-05-16 Salzmann Peter Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 Jacques Rachelle Suzanne Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 HOLMER ALAN F Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 CATLIN AVERY W Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 Ben Yong Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-05-16 Altmeyer Anne Director Grant or award · Stock Option (right to buy) +2,783 2,783
2024-04-10 Moran Sean F. Chief Financial Officer Option exercise +1,787 $30.00 $54K 48,605
2024-04-10 Moran Sean F. Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −1,787 0
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +29,342 $41.23 $1.2M 1,754,342
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +24,983 $42.25 $1.1M 1,779,325
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +18,548 $43.26 $802K 1,797,873
2024-03-08 Cormorant Asset Management, LP 10% owner Purchase +61,668 $44.62 $2.8M 1,859,541

Page 7 of 10 · 200 trades